Yazılar

Samsung to Acquire U.S. Healthcare Platform Xealth to Boost Mobile Health Business

/in /tarafından

Samsung Electronics announced on Tuesday it has signed an agreement to acquire Xealth, a U.S.-based digital healthcare platform, aiming to expand its mobile healthcare services. The financial terms of the deal were not disclosed.

Samsung said the acquisition is intended to create synergy by combining its advanced wearable technology with Xealth’s platform, which manages digital health programs and connects care providers—including over 500 U.S. hospitals—with patients through data integration.

This move aligns with Samsung’s broader strategy to diversify beyond its traditional semiconductor and smartphone operations. The company is increasingly investing in growth areas such as medical technology, consumer audio, climate control systems, and robotics.

Earlier this year, Samsung agreed to acquire Germany’s FlaktGroup for €1.5 billion ($1.68 billion), targeting the booming demand for data center cooling, driven by AI projects. At a March shareholder meeting, Chairman Jay Y. Lee emphasized Samsung’s focus on “meaningful” acquisitions to drive growth, especially after falling behind rivals in the AI chip market led by Nvidia.

Notably, on the same day as the Xealth announcement, Samsung forecasted a sharp 56% decline in its second-quarter operating profit, mainly due to weak AI chip sales—raising investor concerns about the company’s semiconductor business recovery.

Roper Technologies to Acquire CentralReach for $1.65 Billion

/in /tarafından

Roper Technologies has agreed to acquire healthcare technology firm CentralReach for approximately $1.65 billion from Insight Partners, the company announced on Monday. This acquisition marks a strategic move for Roper as it seeks to strengthen its position amid weak enterprise spending that has delayed contract renewals.

Roper’s CEO, Neil Hunn, highlighted that CentralReach fits the company’s long-standing acquisition criteria, offering fast organic growth potential and the ability to expand margins under Roper’s ownership. CentralReach is recognized for its niche market leadership and high recurring revenue mix.

The deal is expected to contribute around $175 million to Roper’s revenue and $75 million in EBITDA for the 12 months ending June 30, 2026. CentralReach specializes in providing software and services for therapists working with individuals diagnosed with autism spectrum disorder and related intellectual and developmental disabilities.

The transaction is anticipated to close by April or May 2025, and Roper’s shares saw a 1.1% increase in early trading.